120 related articles for article (PubMed ID: 3709641)
1. PY 108-068--acute effects of a single oral dose in chronic stable angina.
de Buitleir M; Krikler S; Krikler DM
Eur J Clin Pharmacol; 1986; 30(2):167-70. PubMed ID: 3709641
[TBL] [Abstract][Full Text] [Related]
2. Objective evaluation of PY-108-068, a new calcium channel inhibitor for the treatment of chronic stable angina pectoris.
O'Hara MJ; Khurmi NS; Bowles MJ; Raftery EB
Eur Heart J; 1985 Aug; 6(8):689-94. PubMed ID: 4054138
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of PY 108-068, a new calcium channel blocker, for angina pectoris.
de Buitleir M; Krikler S; Krikler DM
Am J Cardiol; 1986 Jan; 57(1):15-9. PubMed ID: 3079940
[TBL] [Abstract][Full Text] [Related]
4. Short- and long-term efficacy of nicardipine, assessed by placebo-controlled single- and double-blind crossover trials in patients with chronic stable angina.
Khurmi NS; Bowles MJ; Bala Subramanian V; Raftery EB
J Am Coll Cardiol; 1984 Nov; 4(5):908-17. PubMed ID: 6386933
[TBL] [Abstract][Full Text] [Related]
5. Addition of zatebradine, a direct sinus node inhibitor, provides no greater exercise tolerance benefit in patients with angina taking extended-release nifedipine: results of a multicenter, randomized, double-blind, placebo-controlled, parallel-group study. The Zatebradine Study Group.
Frishman WH; Pepine CJ; Weiss RJ; Baiker WM
J Am Coll Cardiol; 1995 Aug; 26(2):305-12. PubMed ID: 7608428
[TBL] [Abstract][Full Text] [Related]
6. Randomized double-blind placebo-controlled comparison of nicardipine and nifedipine in patients with chronic stable angina pectoris.
Bowles MJ; Khurmi NS; O'Hara MJ; Raftery EB
Chest; 1986 Feb; 89(2):260-5. PubMed ID: 3510823
[TBL] [Abstract][Full Text] [Related]
7. A dose-ranging, placebo-controlled, double-blind trial of nisoldipine in effort angina: duration and extent of antianginal effects.
Lam J; Chaitman BR; Crean P; Blum R; Waters DD
J Am Coll Cardiol; 1985 Aug; 6(2):447-52. PubMed ID: 3894474
[TBL] [Abstract][Full Text] [Related]
8. Lack of negative inotropic effects of the new calcium antagonist Ro 40-5967 in patients with stable angina pectoris.
Portegies MC; Schmitt R; Kraaij CJ; Braat SH; Gassner A; Hagemeijer F; Pozenel H; Prager G; Viersma JW; van der Wall EE
J Cardiovasc Pharmacol; 1991 Nov; 18(5):746-51. PubMed ID: 1723772
[TBL] [Abstract][Full Text] [Related]
9. Comparative antianginal effects of nisoldipine and nifedipine in patients with chronic stable angina.
Crean PA; Waters DD; Lam J; Chaitman BR
Am Heart J; 1987 Feb; 113(2 Pt 1):261-5. PubMed ID: 3544754
[TBL] [Abstract][Full Text] [Related]
10. Antianginal efficacy and improved exercise performance with timolol. Twice-daily beta blockade in ischemic heart disease.
Harris FJ; Low RI; Paumer L; Amsterdam EA; Mason DT
Am J Cardiol; 1983 Jan; 51(1):13-8. PubMed ID: 6129794
[TBL] [Abstract][Full Text] [Related]
11. Nicardipine for stable angina pectoris.
Scheidt S; Lewinter MM; Hermanovich J; Venkataraman K; Freedman D
Br J Clin Pharmacol; 1985; 20 Suppl 1(Suppl 1):178S-186S. PubMed ID: 3927958
[TBL] [Abstract][Full Text] [Related]
12. Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris: a 3-month randomised, double-blind, multicentre, noninferiority trial.
Ruzyllo W; Tendera M; Ford I; Fox KM
Drugs; 2007; 67(3):393-405. PubMed ID: 17335297
[TBL] [Abstract][Full Text] [Related]
13. Improvement in exercise performance with nisoldipine, a new second-generation calcium blocker, in stable angina patients.
Lopez LM; Rubin MR; Holland JP; Mehta JL
Am Heart J; 1985 Nov; 110(5):991-6. PubMed ID: 3933316
[TBL] [Abstract][Full Text] [Related]
14. Clinical safety and efficacy of once-a-day amlodipine for chronic stable angina pectoris.
Glasser SP; West TW
Am J Cardiol; 1988 Sep; 62(9):518-22. PubMed ID: 2970788
[TBL] [Abstract][Full Text] [Related]
15. Ambulatory monitoring and exercise testing in the evaluation of a new long-acting calcium ion antagonist KB-944 (Fostedil) for the treatment of exertional angina pectoris.
Khurmi NS; Bowles MJ; O'Hara MJ; Lahiri A; Raftery EB
Int J Cardiol; 1985 Nov; 9(3):289-302. PubMed ID: 3902675
[TBL] [Abstract][Full Text] [Related]
16. Effects of bepridil on exercise tolerance in chronic stable angina: a double-blind, randomized, placebo-controlled, crossover trial.
Hill JA; O'Brien JT; Scott E; Conti CR; Pepine CJ
Am J Cardiol; 1984 Mar; 53(6):679-83. PubMed ID: 6367414
[TBL] [Abstract][Full Text] [Related]
17. Combination therapy with metoprolol and nifedipine versus monotherapy in patients with stable angina pectoris. Results of the International Multicenter Angina Exercise (IMAGE) Study.
Savonitto S; Ardissiono D; Egstrup K; Rasmussen K; Bae EA; Omland T; Schjelderup-Mathiesen PM; Marraccini P; Wahlqvist I; Merlini PA; Rehnqvist N
J Am Coll Cardiol; 1996 Feb; 27(2):311-6. PubMed ID: 8557899
[TBL] [Abstract][Full Text] [Related]
18. Interim report of multicenter double-blind, placebo-controlled studies of nifedipine in chronic stable angina.
Mueller HS; Chahine RA
Am J Med; 1981 Oct; 71(4):645-57. PubMed ID: 6792916
[TBL] [Abstract][Full Text] [Related]
19. [Acute effects of propranolol and its association with nifedipine in aged patients with effort stable angina. Randomized double-blind crossover study, under placebo control].
Santamaria F; Sestito M; Lirato C; Di Palma A; De Rosa ML; Iannuzzi L; Pandolfi E; Cicatiello AM; Parlati S
Minerva Cardioangiol; 1993 Apr; 41(4):139-45. PubMed ID: 8332270
[TBL] [Abstract][Full Text] [Related]
20. [Anti-angina effect of gallopamil in comparison with another calcium antagonist and a placebo].
Hopf R; Drews H; Kaltenbach M
Z Kardiol; 1984 Sep; 73(9):578-85. PubMed ID: 6391005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
